Mariner
AVNS icon

Mariner’s Avanos Medical AVNS Stock Holding History

Mariner’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$288K Buy
20,525
+1,567
+8% +$21.1K ﹤0.01% 2918
2025
Q4 		$213K Sell
18,958
-1,229
-6% -$14.1K ﹤0.01% 3120
2025
Q3 		$233K Buy
20,187
+6,322
+46% +$74K ﹤0.01% 3034
2025
Q2 		$170K Buy
+13,865
New +$174K ﹤0.01% 3105
2025
Q1 		– Sell
-10,655
Closed -$170K – 3447
2024
Q4 		$170K Buy
10,655
+1,625
+18% +$32.2K ﹤0.01% 3062
2024
Q3 		$217K Buy
+9,030
New +$206K ﹤0.01% 2875
2024
Q1 		– Sell
-16,069
Closed -$360K – 3140
2023
Q4 		$360K Buy
16,069
+2,778
+21% +$57.3K ﹤0.01% 2189
2023
Q3 		$269K Sell
13,291
-1,645
-11% -$37.3K ﹤0.01% 2257
2023
Q2 		$382K Buy
14,936
+4,015
+37% +$106K ﹤0.01% 1932
2023
Q1 		$325K Sell
10,921
-735
-6% -$21.3K ﹤0.01% 2005
2022
Q4 		$315K Sell
11,656
-106
-0.9% -$2.59K ﹤0.01% 1986
2022
Q3 		$256K Sell
11,762
-555
-5% -$14.5K ﹤0.01% 1880
2022
Q2 		$337K Buy
+12,317
New +$354K ﹤0.01% 1250

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Mariner's AVNS Position: Q1 2026 in Review

Mariner increased its Avanos Medical (AVNS) stake by 8.3% in Q1 2026, buying an estimated $21.1K and bringing the position to 20,525 shares worth $288K. The position accounts for ﹤0.01% of the portfolio, ranked #2918.

Mariner first reported a position in AVNS in Q2 2022 and has held it in 13 quarters since. The position peaked at $382K in Q2 2023. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.

  • Mariner held 20,525 shares of Avanos Medical worth $288K as of Q1 2026.
  • Mariner bought 1,567 Avanos Medical shares in Q1 2026, an estimated $21.1K.
  • Avanos Medical made up ﹤0.01% of Mariner's portfolio in Q1 2026, its #2918 holding.
  • Mariner first reported a position in Avanos Medical in Q2 2022 and has held it in 13 quarters since.
  • Mariner's Avanos Medical position peaked at $382K in Q2 2023.
  • 257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.

Based on Mariner's 13F filing for Q1 2026, filed 13 May 2026.